p130 is dispensable in peripheral T lymphocytes: Evidence for functional compensation by p107 and pRB

Molecular and Cellular Biology

Volumn 18, Issue 1, 1998, Pages 206-220

  Mulligan, George J ^b   Wong, James ^b   Jacks, Tyler ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; T LYMPHOCYTE;

ANIMALIA;

EID: 0031983190     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.1.206     Document Type: Article

References (81)

1. Aagaard, L., J. Lukas, J. Bartkova, A. A. Kjerulff, M. Strauss, and J. Bartek. 1995. Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct subsets of human cancer cell lines. Int. J. Cancer 61:115-120.
2. Almasan, A., R. Kelly, E. Lee, A. Bradley, W. Li, J. Bertino, and G. Wahl. 1995. Deficiency of the retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F responsive genes, and apoptosis. Proc. Natl. Acad. Sci. USA 92:5436-5440.
3. Bartkova, J., J. Lukas, P. Guldberg, J. Alsner, A. Kirkin, J. Zeuthen, and J. Bartek. 1996. The p16-cyclinD/cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res. 56:5475-5483.
4. Beijersbergen, R. L., L. Carlee, R. M. Kerkhoven, and R. Bernards. 1995. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev. 9:1340-1353.
5. Beijersbergen, R. L., R. M. Kerkhoven, L. Zhu, L. Carlee, P. M. Voorhoeve, and R. Bernards. 1994. E2F-4, a new member of the E2F family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8:2680-2690.
6. Braun, T., and H. Arnold. 1996. myf-5 and myoD genes are activated in distinct mesenchymal stem cells and determine different skeletal muscle cell lineages. EMBO J. 15:310-318.
7. Cao, L., B. Faha, M. Dembski, L. H. Tsai, E. Harlow, and N. Dyson. 1992. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355:176-179.
8. Chen, G., C. T. Guy, H. W. Chen, N. Hu, E. Y. Lee, and W. H. Lee. 1996. Molecular cloning and developmental expression of mouse p130, a member of the retinoblastoma gene family. J. Biol. Chem. 271:9567-9572.
9. Chen, J., J. Gorman, V. Stewart, B. Williams, T. Jacks, and F. W. Alt. 1993. Generation of normal lymphocyte populations of Rb-deficient ES cells: analysis of gene function by RAG-2-deficient blastocyst complementation. Curr. Biol. 3:405-413.
10. Chen, S., and E. Paucha. 1990. Identification of a region of simian virus 40 large T antigen required for cell transformation. J. Virol. 64:3350-3357.
11. Chittenden, T., D. M. Livingston, and J. A. DeCaprio. 1993. Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2F. Mol. Cell. Biol. 13:3975-3983.
12. Christensen, J., and M. Imperiale. 1995. Inactivation of the retinoblastoma susceptibility protein is not sufficient for the transforming function of the conserved region 2-like domain of simian virus 40 large T antigen. J. Virol. 69:3945-3948.
13. Clarke, A. R., E. R. Maandag, M. van Roon, N. M. T. van der Lugt, M. van der Valk, M. L. Hooper, A. Berns, and H. te Riele. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359:328-330.
14. Claudio, P. P., A. De Luca, C. M. Howard, A. Baldi, E. J. Firpo, A. Koff, M. G. Paggi, and A. Giordano. 1996. Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res. 56:2003-2008.
15. Claudio, P. P., C. M. Howard, A. Baldi, A. De Luca, Y. Fu, G. Condorelli, Y. Sun, N. Colburn, B. Calabretta, and A. Giordano. 1994. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res. 54:5556-5560.
16. Cobrinik, D. 1996. Regulatory interactions among E2Fs and cell cycle control proteins. Curr. Top. Microbiol. Immunol. 208:31-61.
17. Cobrinik, D., M. Lee, G. Hannon, G. Mulligan, R. Bronson, N. Dyson, E. Harlow, D. Beach, R. Weinberg, and T. Jacks. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10:1633-1644.
18. Cobrinik, D., P. Whyte, D. S. Peeper, T. Jacks, and R. A. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7:2392-2404.
19. Corbeil, H. B., P. Whyte, and P. E. Branton. 1995. Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene 11:909-920.
20. Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243:355-361.
21. 1/S-regulatory genes. Mol. Cell. Biol. 15:4215-1224.
22. 21a.Dyson, N., M. Dembski, A. Fattaey, C. Ngwu, M. Ewen, and K. Helin. 1993. Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associaled E2F-1. J. Virol. 66:7641-7647.
23. Ernst, D. N., D. Weigle, D. J. Noonan, D. N. McQuitty, and M. V. Hobbs. 1993. The age-associated increase in IFN synthesis by mouse CD8+ T cells correlates with shifts in the frequencies of cell subsets defined by membrane CD44, CD45RB, 3G11 and MEL-14 expression. J. Immunol. 151:575-581.
24. Ewen, M. E., Y. Xing, J. B. Lawrence, and D. M. Livingston. 1991. Molecular cloning, chromosomal mapping and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66:1155-1164.
25. Ginsberg, D., G. Vairo, T. Chittenden, Z. Xiao, G. Xu, K. L. Wydner, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:2665-2679.
26. Hannon, G. J., D. Demetrick, and D. Beach. 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev. 7:2378-2391.
27. He, J., J. Olson, and C. James. 1995. Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res. 55:4833-4836.
28. Helin, K., J. A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337-350.
29. 1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16:2402-2407.
30. Hijmans, E. M., P. M. Voorhoeve, R. L. Beijersbergen, L. J. van't Veer, and R. Bernards. 1995. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15:3082-3089.
31. Huet, X., A. Rech, A. Plet, and J. Blanchard. 1996. Cyclin A expression is under negative transcriptional control during the cell cycle. Mol. Cell. Biol. 16:3789-3798.
32. Hurford, R. K., D. Cobrinik, M. Lee, and N. Dyson. 1997. pRB and p107/ p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11:1447-1463.
33. Ikeda, M., L. Jakoi, and J. Nevins. 1996. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 93:3215-3220.
34. Jacks, T., A. Fazeli, E. Schmidt, R. Bronson, M. Goodell, and R. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature 359:295-300.
35. Janeway, C., and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell 76:275-285.
36. Johnson, D. 1995. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene 11:1685-1692.
37. Johnson, D. G., J. K. Schwarz, W. D. Cress, and J. R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349-352.
38. Kaelin, W. G., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, M. A. Blanar, et al. 1992. Expression cloning of a cDNA encoding a retinoblasloma binding protein with E2F-like properties. Cell 70:351-364.
39. Kamb, A., N. A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S. V. Tavtigian, E. Stockert, R. S. Day, B. E. Johnson, and M. H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
40. Kim, K. K., M. H. Soonpaa, H. Wang, and L. J. Field. 1995. Developmental expression of p107 mRNA and evidence for alternative splicing of the p107 (RBL1) gene product. Genomics 28:520-529.
41. Kruisbeek, A. 1991. Units 4.2.1 and 3.12.1. In R. Coico (ed.), Current protocols in immunology. John Wiley & Sons, New York, N.Y.
42. Lam, E., J. D. Morris, R. Davies, T. Crook, R. Watson, and K. H. Vousden. 1994. HPV16 E7 oncoprotein deregulates B-myh expression: correlation with targetting of p107/E2F complexes. EMBO J. 13:871-878.
43. La Thangue, N. 1994. DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control. Curr. Opin. Cell Biol. 6:443-450.
44. Lee, E. Y.-H. P., C.-Y. Chang, N. Hu, Y.-C. J. Wang, C.-C. Lai, K. Herrup, and W.-H. Lee. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288-295.
45. Lee, M., B. Williams, G. Mulligan, S. Mukai, R. Bronson, N. Dyson, E. Harlow, and T. Jacks. 1996. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10:1621-1632.
46. Lees, J. A., M. Saito, M. Vidal, M. Valentino, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13:7813-7825.
47. Li, Y., C. Graham, S. Lacy, A. M. V. Duncan, and P. Whyte. 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev. 7:2366-2377.
48. Lukas, J., B. O. Petersen, K. Holm, J. Bartek, and K. Helin. 1996. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-medialed growth suppression. Mol. Cell. Biol. 16:1047-1057.
49. Maandag, E. C. R., M. van der Valk, M. Vlaar, C. Feltkamp, J. O'Brien, M. van Roon, N. van der Lugt, A. Berns, and H. te Riele. 1994. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13:4260-4268.
50. Mayol, X., J. Garriga, and X. Grana. 1995. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene 11:801-808.
51. Moberg, K., M. A. Starz, and J. A. Lees. 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16:1436-1449.
52. Nevins, J. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
53. Nevins, J. R. 1994. Cell cycle targets of the DNA tumor viruses. Curr. Opin. Genet. Dev. 4:130-134.
54. Nourse, J., E. Firpo, W. M. Flanagan, S. Coats, K. Polyak, M. Lee, J. Massague, G. Crabtree, and J. M. Roberts. 1994. Interleukin-2-mediated elimination of the p27 kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573.
55. Okamoto, A., D. Demetrick, A. Spillare, K. Hagiwara, S. Hussain, W. Bennet, K. Forrester, B. Gerwin, M. Serrano, D. Beach, et al. 1994. Mutations and altered expression of p16INK4A in human cancer. Proc. Natl. Acad. Sci. USA 91:11045-11049.
56. Qin, X. Q., T. Chittenden, D. M. Livingston, and W. Kaelin, Jr. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:953-964.
57. Qin, X. Q., D. M. Livingston, W. Kaelin, Jr., and P. D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91:10918-10922.
58. Rudnicki, M. A., P. Schnegelsberg, R. Stead, T. Braun, H. Arnold, and J. R. Nevins. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75:1351-1359.
59. Sanchez, A., and B. Dynlacht. 1996. Transcriptional control of the cell cycle Curr. Opin. Cell Biol. 8:318-324.
60. Sardet, C., M. Vidal, D. Cobrinik, Y. Geng, C. Onufryk, A. Chen, and R. A. Weinberg. 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92:2403-2407.
61. Schwarz, J. K., S. H. Devoto, E. J. Smith, S. P. Chellapan, L. Jakoi, and J. R. Nevins. 1993. Interactions of the p107 and Rh proteins with E2F during the cell proliferation response. EMBO J. 12:1013-1020.
62. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
63. Shin, E. K., A. Shin, C. Pauldin, B. Schaffhausen, and A. Yee. 1995. Multiple changes in E2F function and regulation occur upon muscle differentiation. Mol. Cell. Biol. 15:2252-2262.
64. Shirodkar, S. E., M., J. A. DeCaprio, J. Morgan, D. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68:157-166.
65. 1 cell state. Mol. Cell. Biol. 16:6965-6976.
66. Starostik, P., K. N. B. Chow, and D. C. Dean. 1996. Transcriptional repression and growth suppression by the p107 pocket protein. Mol. Cell. Biol. 16:3606-3614.
67. Studbal, H., J. Zalvide, K. S. Campbell, C. Schweitzer, T. Roberts, and J. DeCaprio. 1997. Inactivation of the RB-related proteins p107 and p130 mediated by the J domain of simian virus 40 large T antigen. Mol. Cell. Biol. 17:4979-4989.
68. Tivol, E., F. Borriello, A. N. Schweitzer, W. P. Lynch, W. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547.
69. Tommasi, S., and G. Pfeifer. 1995. In vivo structure of the human cdc2 promoter: release of a p130-E2F4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol. Cell. Biol. 15:6901-6913.
70. Vairo, G., D. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9:869-881.
71. Wang, J. Y., E. S. Knudsen, and P. J. Welch. 1994. The retinoblastoma tumor suppressor protein. Adv. Cancer Res. 64:25-85.
72. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
73. Weintraub, S. J., K. N. Chow, R. X. Luo, S. H. Zhang, S. He, and D. C. Dean. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812-815.
74. Weintraub, S. J., C. A. Prater, and D. C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358:259-261.
75. Williams, B. O., E. M. Schmitt, L. Remington, R. T. Bronson, D. M. Albert, R. A. Weinberg, and T. Jacks. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J., in press.
76. Yeager, T., W. Stadler, C. Belair, J. Puthenveettil, O. Olopade, and C. Reznikoff. 1995. Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res. 55:493-497.
77. Zalvide, J., and J. A. DeCaprio. 1995. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol. 15:5800-5810.
78. Zhu, L., G. Enders, J. A. Lees, R. L. Beijersbergen, R. Bernards, and E. Harlow. 1995. The pRb-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J. 14:1904-1913.
79. Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111-1125.
80. Zuniga-Pflucker, J. C., and M. Lenardo. 1996. Regulation of thymocyte development from immature progenitors. Curr. Opin. Immunol. 8:215-224.
81. Zwicker, J., N. Liu, K. Engeland, F. C. Lucibello, and R. Muller. 1996. Cell cycle regulation of E2F site occupancy in vivo. Science 271:1595-1597.